Phase I study of intermittent dosing of OSI-906, a dual tyrosine kinase inhibitor of insulin-like growth factor-1 receptor (IGF- 1R) and insulin receptor (IR) in patients with advanced solid tumors.
More chatter has emerged about a new high-end AMD gaming GPU possibly waiting in the wings, with the latest rumors saying that the AMD Radeon RX 9090 XT is "40% faster" than AMD's current top-end ...
SHANGHAI, Sept. 23, 2025 /PRNewswire/ -- Tokyo born street-wear label 9090 has officially landed in mainland China market with the opening of its first Shanghai pop-up in this August. The launch is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback